• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday

    11/1/22 3:31:01 AM ET
    $ACOR
    $AHI
    $APGN
    $ARAV
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $ACOR alert in real time by email

    Gainers

    • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product candidates.
    • Acorda Therapeutics, Inc. (NASDAQ:ACOR) gained 63.4% to close at $1.07. Acorda Therapeutics recently provided long-term financial guidance.
    • 1847 Holdings LLC (NASDAQ:EFSH) shares jumped 39.9% to close at $2.63 on Monday after the company reported it sees over $60 million in revenue and over $7 million in cash flow from operations in 2023 from its existing portfolio.
    • Actinium Pharmaceuticals, Inc. (NYSE:ATNM) surged 39.2% to close at $13.54 after the company announced the results from its pivotal Phase 3 SIERRA trial of iomab-b in patients with active relapsed or refractory acute myeloid leukemia met its primary endpoint of durable complete remission.
    • Shineco, Inc. (NASDAQ:SISI) gained 38% to settle at $1.09. Shineco recently announced plans to acquire 51% equity interest in Changzhou Biowin Pharmaceutical Co., Ltd.
    • Getty Images Holdings, Inc. (NYSE:GETY) shares gained 34.7% to close at $6.80.
    • Sientra, Inc. (NASDAQ:SIEN) gained 31.1% to settle at $0.2748.
    • Aravive, Inc. (NASDAQ:ARAV) climbed 23.6% to close at $1.31. Aravive recently announced approximately $41.5 million private placement financing.
    • Arcadia Biosciences, Inc. (NASDAQ:RKDA) rose 20.3% to close at $0.4210.
    • Monopar Therapeutics Inc. (NASDAQ:MNPR) gained 19.4% to close at $2.46.
    • China Liberal Education Holdings Limited (NASDAQ:CLEU) surged 18.9% to close at $1.57.
    • Gritstone bio, Inc. (NASDAQ:GRTS) gained 18.8% to close at $3.22. Piper Sandler initiated coverage on Gritstone Bio with an Overweight rating and announced a price target of $6.
    • TrueCar, Inc. (NASDAQ:TRUE) surged 18.4% to close at $1.80. JP Morgan upgraded TrueCar from Underweight to Overweight.
    • Nikola Corporation (NASDAQ:NKLA) gained 18.4% to close at $3.79 after the company announced a hydrogen supply collaboration with Keystate.
    • Canopy Growth Corporation (NASDAQ:CGC) rose 18.4% to settle at $3.73. Shares of cannabis companies traded higher after Senate Majority Leader Schumer said Congress is 'very close' to passing a marijuana banking and expungements bill.
    • Enservco Corporation (NASDAQ:ENSV) gained 17.6% to close at $2.61.
    • Steakholder Foods Ltd. (NASDAQ:STKH) jumped 17.2% to close at $2.32.
    • Farmer Bros. Co. (NASDAQ:FARM) rose 16.7% to settle at $6.00.
    • Performant Financial Corporation (NASDAQ:PFMT) gained 16% to settle at $2.32.
    • Renalytix Plc (NASDAQ:RNLX) rose 13.4% to close at $1.95 after reporting FY22 results.
    • Cimpress plc (NASDAQ:CMPR) gained 13.2% to close at $23.28. Barrington Research maintained Cimpress with an Outperform and lowered the price target from $76 to $57.
    • Gol Linhas Aéreas Inteligentes S.A. (NYSE:GOL) climbed 12.5% to close at $3.70 amid volatility in Brazilian stocks following the election of Lula as president.
    • RPC, Inc. (NYSE:RES) surged 12.4% to close at $11.13. The company recently posted upbeat quarterly earnings.
    • Global Partners LP (NYSE:GLP) gained 12.2% to close at $33.58.
    • Tilray Brands, Inc. (NASDAQ:TLRY) rose 12.1% to settle at $4.07. Shares of cannabis companies traded higher after Senate Majority Leader Schumer said Congress is 'very close' to passing a marijuana banking and expungements bill.
    • Silicom Ltd. (NASDAQ:SILC) climbed 11.9% to close at $44.66 following upbeat Q3 results.
    • Anterix Inc. (NASDAQ:ATEX) rose 11.3% to close at $38.35.
    • Opera Limited (NASDAQ:OPRA) gained 10.7% to settle at $4.77 after Cowen maintained an Outperform rating on the stock and raised its price target form $10.50 to $12.50.
    • Insperity, Inc. (NYSE:NSP) gained 10.2% to close at $118.02 after the company reported better-than-expected Q3 EPS results and raised its FY22 EPS guidance above analyst estimates.
    • Presto Automation, Inc. (NASDAQ:PRST) jumped 10.1% to close at $1.85.
    • First Solar, Inc. (NASDAQ:FSLR) surged 9.7% to close at $145.57 after B of A Securities maintained a Buy rating on the stock and raised its price target from $138 to $165.
    • Berkeley Lights, Inc. (NASDAQ:BLI) rose 7.3% to close at $2.22. Berkeley Lights is expected to report Q3 financial results on November 8, 2022.

     


    Losers

    • Quanergy Systems, Inc. (NYSE:QNGY) shares tumbled 68.2% to close at $1.05 on Monday after the company priced its $16.7 million offering.
    • Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) dipped 59.8% to close at $3.61 after the FDA Oncologic Drugs Advisory Committee voted Y-mAbs did not provide sufficient evidence to conclude its treatment improves overall survival.
    • TuSimple Holdings Inc. (NASDAQ:TSP) dipped 45.6% to close at $3.43 following a media report stating the company is being investigated over ties to a Chinese startup. TuSimple board terminated CEO, President, and Chief Technology Officer Dr. Xiaodi Hou from his position.
    • Satixfy Communications Ltd. (NASDAQ:SATX) dropped 44.5% to close at $16.31.
    • Argo Blockchain plc (NASDAQ:ARBK) declined 43.7% to close at $1.11 after the company announced it believes its previously announced non-binding LOI with a strategic investor to raise $27 million via a subscription for ordinary shares will no longer be consummated. Roth Capital downgraded Argo Blockchain from Neutral to Sell and lowered the price target from $2 to $0.25.
    • Quotient Limited (NASDAQ:QTNT) declined 37.4% to close at $0.0806. Quotient announced intent to effect 1-for-40 reverse stock split November 22.
    • Instil Bio, Inc. (NASDAQ:TIL) fell 37.1% to close at $3.30 after the company voluntarily paused enrollment of its ongoing clinical trials.
    • Ucommune International Ltd (NASDAQ:UK) declined 29.4% to close at $1.27.
    • D-Wave Quantum Inc. (NASDAQ:QBTS) fell 24.4% to close at $2.91.
    • Starry Group Holdings, Inc. (NYSE:STRY) dipped 23.8% to close at $0.2210. Citigroup downgraded Starry Group Holdings from Neutral to Sell and lowered the price target from $3.75 to $0.25.
    • ReTo Eco-Solutions, Inc. (NASDAQ:RETO) dropped 22.5% to close at $0.55.
    • Genius Group Limited (NYSE:GNS) fell 21.5% to close at $1.06. Genius Group recently announced 1H revenue of $7.44 million.
    • Tantech Holdings Ltd (NASDAQ:TANH) dropped 21.4% to close at $0.1294 after the company announced a reverse stock split.
    • Inventiva S.A. (NYSE:IVA) fell 21.4% to close at $4.58. Inventiva said AbbVie communicated that they decided to stop the development of cedirogant (ABBV-157) for the treatment of autoimmune disease.
    • Leju Holdings Limited (NYSE:LEJU) declined 18.8% to close at $1.32.
    • Golden Sun Education Group Limited (NASDAQ:GSUN) dropped 18.6% to close at $21.16.
    • ESSA Pharma Inc. (NASDAQ:EPIX) dipped 18.4% to close at $3.60 after the company announced Janssen Research and Development is suspending enrollment into the Phase 1 clinical study of EPI-7386 with apalutamide or EPI-7386 with abiraterone acetate plus prednisone.
    • Schmitt Industries, Inc. (NASDAQ:SMIT) dropped 18.2% to close at $1.2850.
    • Freight Technologies, Inc. (NASDAQ:FRGT) fell 17.8% to settle at $0.4193.
    • Edible Garden AG Incorporated (NASDAQ:EDBL) fell 17.2% to close at $0.5702. Edible Garden recently added three new, greenhouse grown, salad kits to its list of Stock Keeping Units (SKU).
    • Ensysce Biosciences, Inc. (NASDAQ:ENSC) dropped 16.8% to close at $3.23. Ensysce Biosciences announced topline results from a human abuse potential (HAP) study for PF614.
    • Apexigen, Inc. (NASDAQ:APGN) declined 14.9% to close at $2.2550.
    • Fangdd Network Group Ltd. (NASDAQ:DUO) fell 13.4% to close at $1.68 after jumping around 27% on Friday.
    • Waterdrop Inc. (NYSE:WDH) fell 12.2% to close at $1.30.
    • T Stamp Inc. (NASDAQ:IDAI) dropped 10.4% to close at $0.8155.
    • GDS Holdings Limited (NYSE:GDS) fell 10.4% to settle at $8.63.
    • Advanced Human Imaging Limited (NASDAQ:AHI) dropped 9.5% to close at $0.48.
    • ON Semiconductor Corporation (NASDAQ:ON) declined 9% to close at $61.43 after the company reported Q3 financial results and issued Q4 guidance.
    • Global Payments Inc. (NYSE:GPN) fell 8.8% to close at $114.26 following downbeat quarterly earnings.
    • Newell Brands Inc. (NASDAQ:NWL) dropped 8.2% to close at $13.81. Barclays downgraded Newell Brands from Equal-Weight to Underweight and lowered the price target from $16 to $11.
    • DoorDash, Inc. (NYSE:DASH) dipped 7.5% to close at $43.53.
    Get the next $ACOR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACOR
    $AHI
    $APGN
    $ARAV

    CompanyDatePrice TargetRatingAnalyst
    First Solar Inc.
    $FSLR
    2/26/2026$245.00Buy → Hold
    Deutsche Bank
    First Solar Inc.
    $FSLR
    2/25/2026$211.00Buy → Hold
    HSBC Securities
    First Solar Inc.
    $FSLR
    2/25/2026$205.00Outperform → Neutral
    Robert W. Baird
    First Solar Inc.
    $FSLR
    2/25/2026$320.00 → $253.00Buy
    TD Cowen
    ON Semiconductor Corporation
    $ON
    2/12/2026$75.00Equal Weight
    Barclays
    D-Wave Quantum Inc.
    $QBTS
    2/12/2026Buy
    TD Cowen
    ON Semiconductor Corporation
    $ON
    2/10/2026Buy → Hold
    The Benchmark Company
    First Solar Inc.
    $FSLR
    1/29/2026$263.00Outperform → Market Perform
    BMO Capital Markets
    More analyst ratings

    $ACOR
    $AHI
    $APGN
    $ARAV
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for DANYELZA issued to Y-MABS THERAPEUTICS INC

    Submission status for Y-MABS THERAPEUTICS INC's drug DANYELZA (SUPPL-8) with active ingredient NAXITAMAB-GQGK has changed to 'Approval' on 03/20/2024. Application Category: BLA, Application Number: 761171, Application Classification:

    3/21/24 10:20:07 AM ET
    $YMAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $AHI
    $APGN
    $ARAV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    First Solar downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded First Solar from Buy to Hold and set a new price target of $245.00

    2/26/26 7:10:22 AM ET
    $FSLR
    Semiconductors
    Technology

    First Solar downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded First Solar from Buy to Hold and set a new price target of $211.00

    2/25/26 10:07:01 AM ET
    $FSLR
    Semiconductors
    Technology

    First Solar downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded First Solar from Outperform to Neutral and set a new price target of $205.00

    2/25/26 7:39:36 AM ET
    $FSLR
    Semiconductors
    Technology

    $ACOR
    $AHI
    $APGN
    $ARAV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Insperity Celebrates 40 Years of Excellence

    Marking Four Decades of Gratitude to Employees, Clients and Communities Insperity, Inc. (NYSE:NSP), a leading provider of human resources and business performance solutions, is proud to announce its 40th anniversary today. As a founder of the professional services organization (PEO), Insperity has helped shape the evolution of HR from an administrative necessity to a strategic driver of business success and continues to innovate for the needs of small and midsize businesses. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305580972/en/ "Throughout our history, Insperity has navigated changing markets and generational shifts

    3/5/26 5:50:00 PM ET
    $NSP
    Professional Services
    Consumer Discretionary

    VistaPrint Launches New Generative AI Logomaker, Turning Small Business Ideas Into Professional, Print-Ready Logos in Minutes

    A generative AI logo design tool created specifically for small businesses, AI Logomaker by VistaPrint bypasses generic templates and complex prompts to help entrepreneurs build their brands VistaPrint, the print and design partner to small businesses, today announced the launch of AI Logomaker by VistaPrint, a new generative AI logo design tool that is purpose-built for small businesses. AI Logomaker by VistaPrint delivers personalized, high-quality logos with access to free, digital and print-ready scalable files, making it easier than ever for small business owners (SBOs) to bring their ideas to life without the need for design skills or a large budget. This press release features mul

    3/5/26 9:00:00 AM ET
    $CMPR
    Publishing
    Consumer Discretionary

    Royal Cup Signs Agreement to Acquire Farmer Brothers Coffee Co.

    Royal Cup Coffee and Tea ("Royal Cup"), a leading manufacturer and distributor of premium coffee and tea, announced today that it has entered into a definitive agreement to acquire Farmer Brothers Coffee Co. (NASDAQ:FARM) ("Farmer Brothers" or the Company), a national coffee roaster, wholesaler and distributor. As part of the transaction, Royal Cup will acquire all outstanding shares of Farmer Brothers stock in an all-cash transaction. The agreement brings together two established coffee and tea organizations, representing nearly 250 years of combined industry experience, and will expand Royal Cup's national reach and strengthen its capabilities across foodservice and retail channels. T

    3/4/26 9:15:00 AM ET
    $FARM
    Packaged Foods
    Consumer Staples

    $ACOR
    $AHI
    $APGN
    $ARAV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    VP - Global Controller and CAO Theurer Nathan B. sold $18,119 worth of shares (92 units at $196.95), closing all direct ownership in the company (SEC Form 4)

    4 - FIRST SOLAR, INC. (0001274494) (Issuer)

    3/5/26 7:03:18 PM ET
    $FSLR
    Semiconductors
    Technology

    Chief Manufacturing Officer Verma Kuntal Kumar sold $143,380 worth of shares (728 units at $196.95), decreasing direct ownership by 9% to 7,606 units (SEC Form 4)

    4 - FIRST SOLAR, INC. (0001274494) (Issuer)

    3/5/26 7:01:59 PM ET
    $FSLR
    Semiconductors
    Technology

    Chief Technology Officer Gloeckler Markus sold $716,898 worth of shares (3,640 units at $196.95), decreasing direct ownership by 31% to 8,037 units (SEC Form 4)

    4 - FIRST SOLAR, INC. (0001274494) (Issuer)

    3/5/26 7:00:48 PM ET
    $FSLR
    Semiconductors
    Technology

    $ACOR
    $AHI
    $APGN
    $ARAV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Johnson Joia M bought $99,345 worth of shares (1,213 units at $81.90), increasing direct ownership by 38% to 4,386 units (SEC Form 4)

    4 - GLOBAL PAYMENTS INC (0001123360) (Issuer)

    2/23/26 5:49:04 PM ET
    $GPN
    Real Estate

    President and CEO Kras James E. bought $2,050 worth of shares (3,700 units at $0.55), increasing direct ownership by 102% to 7,317 units (SEC Form 4)

    4 - Edible Garden AG Inc (0001809750) (Issuer)

    1/5/26 8:51:35 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    Chief Financial Officer Vu Quan Anh bought $104,925 worth of shares (1,500 units at $69.95) (SEC Form 4)

    4 - Monopar Therapeutics (0001645469) (Issuer)

    12/29/25 12:15:31 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $AHI
    $APGN
    $ARAV
    SEC Filings

    View All

    SEC Form FWP filed by Global Payments Inc.

    FWP - GLOBAL PAYMENTS INC (0001123360) (Subject)

    3/5/26 4:49:50 PM ET
    $GPN
    Real Estate

    T Stamp Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits

    8-K - T Stamp Inc (0001718939) (Filer)

    3/5/26 4:30:44 PM ET
    $IDAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 144 filed by D-Wave Quantum Inc.

    144 - D-Wave Quantum Inc. (0001907982) (Subject)

    3/5/26 4:05:46 PM ET
    $QBTS
    EDP Services
    Technology

    $ACOR
    $AHI
    $APGN
    $ARAV
    Financials

    Live finance-specific insights

    View All

    GDS to Report Fourth Quarter and Full Year 2025 Financial Results Before the Open of the U.S. Market on March 17, 2026

    SHANGHAI, China, March 03, 2026 (GLOBE NEWSWIRE) -- GDS Holdings Limited ("GDS Holdings", "GDS" or the "Company") (NASDAQ:GDS, HKEX: 9698)), a leading developer and operator of high-performance data centers in China, today announced that it will report its fourth quarter and full year 2025 unaudited financial results after the close of the Hong Kong market and before the open of the U.S. market on March 17, 2026. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on Tuesday, March 17, 2026 (8:00 PM Hong Kong Time on the same day). Participants should complete online registration using the link provided below at least 15 minutes before the schedule

    3/3/26 6:00:00 AM ET
    $GDS
    Computer Software: Programming Data Processing
    Technology

    Tilray Brands Acquires BrewDog, a Leading Global Craft Brand, Creating a ~$500 Million Global Craft Beer and Beverage Platform

    Accretive Acquisition of Select Assets Includes Global Brand, UK Brewing Operations and 11 Strategic Brewpubs  Expected to Generate ~$200 Million in Annual Net Revenue and ~$6 - $8 Million of Adjusted EBITDA in Fiscal 2027 Tilray's Global Consolidated Net Revenue Expected to Reach ~$1.2 Billion on an Annualized Basis1 Conference Call Scheduled for 12:30pm ET NEW YORK and LONDON, March 02, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today completed the acquisition of certain highly strategic

    3/2/26 10:17:01 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Global Partners Reports Fourth-Quarter and Full-Year 2025 Financial Results

    Global Partners LP (NYSE:GLP) ("Global Partners" or the "Partnership") today reported financial results for the fourth quarter and full year ended December 31, 2025. CEO Commentary "We closed 2025 with a fourth quarter that reflected the strength and resilience of our integrated platform," said Eric Slifka, President and Chief Executive Officer. "Built and refined over more than 90 years, our diversified business model and broad network provide a durable competitive advantage, positioning us to navigate market cycles and adapt to dynamic market conditions while meeting the needs of the markets, customers and communities we serve. "The flexibility of our business model was reflected in

    2/27/26 8:00:00 AM ET
    $GLP
    Oil Refining/Marketing
    Energy

    $ACOR
    $AHI
    $APGN
    $ARAV
    Leadership Updates

    Live Leadership Updates

    View All

    Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer

    WILMETTE, Ill., March 02, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (NASDAQ:MNPR) ("Monopar" or the "Company"), a clinical‐stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced the appointment of Susan Rodriguez as Chief Commercial and Strategy Officer, effective immediately. In this newly created executive role, Ms. Rodriguez will lead the Company's commercial strategy and infrastructure build-out as Monopar prepares for the planned submission of a New Drug Application ("NDA") to the U.S. Food and Drug Administration ("FDA") in the first half of 2026 for ALXN1840, its late-stage investigational therapy for Wilson d

    3/2/26 8:00:00 AM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    D-Wave Joins Southeastern Quantum Collaborative as Inaugural Member

    D-Wave Quantum Inc. (NYSE:QBTS) ("D-Wave" or the "Company"), the only dual-platform quantum computing company, providing both annealing and gate-model systems, software and services, today joined the Southeastern Quantum Collaborative (SQC) as an inaugural member, along with The University of Alabama in Huntsville, Davidson Technologies, IBM and Alabama A&M University. The SQC will bring together academia, industry and government to accelerate the advancement and application of quantum information science and technology across the Southeast. In addition, it aims to develop the quantum-ready workforce needed to commercialize the technology. Given Davidson hosts a D-Wave Advantage2TM system

    2/19/26 7:00:00 AM ET
    $QBTS
    EDP Services
    Technology

    Global Payments Announces Board Appointment

    Global Payments Inc. (NYSE:GPN), a leading payment technology and software company that powers commerce for businesses of all sizes worldwide, today announced the appointment of Vivek Sankaran as a new independent director to the company's Board of Directors, effective February 19, 2026. "Vivek is a terrific addition to our board of directors," said Troy Woods, chair of the Global Payments Board of Directors. "His deep expertise leading technology and digital transformations, as well as his extensive executive experience at some of the most recognizable global brands, will be an invaluable addition to the leadership of this company." "I am delighted to extend a warm welcome to Vivek, an

    2/18/26 7:00:00 AM ET
    $GPN
    Real Estate

    $ACOR
    $AHI
    $APGN
    $ARAV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Monopar Therapeutics Inc.

    SC 13D/A - Monopar Therapeutics (0001645469) (Subject)

    12/17/24 5:01:42 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance

    $ACOR
    $AHI
    $APGN
    $ARAV
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at Monopar Therapeutics Inc. on Jun 21 Indicate?

    Monopar Therapeutics Inc. has recently seen notable insider activity, with Chief Operating Officer Cittadine Andrew purchasing $25,574 worth of shares on June 21st, 2024. This purchase, comprising 32,508 units at $0.79, increased Cittadine's direct ownership by 21% to 186,132 units as reported in the SEC Form 4. When analyzing this transaction alongside other recent insider activities within the company, interesting patterns and trends start to emerge. Looking back, Cittadine Andrew has been consistently adding to his position in Monopar Therapeutics Inc. over the past few months, showcasing a strong conviction in the company's future prospects. On May 31st, Cittadine Andrew made a substan

    6/22/24 8:00:00 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care